Casdin Capital invests $50 million in Codexis to accelerate strategic growth initiatives
Codexis announces that Casdin Capital, a New York City-based life science-focused investment firm and current stockholder of Codexis, has invested approximately $50 million in Codexis through the purchase of shares of Codexis’ common stock in a private placement. June 20, 2019